ESR2 and breast cancer: It has been reported previously that ERβ plays a critical role in the maintenance of mammary stem cells (MSCs) and breast cancer stem cells (BCSCs); stimulation of ERβ by ERβ agonist, DPN, in BCSCs increased their sphere formation ability, while the knockdown of ERβ in BCSCs reduced sphere formation [25].